Cargando…

Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report

Detalles Bibliográficos
Autores principales: Matsuda, Shogo, Yamamoto, Mahiro, Kotani, Takuya, Takeuchi, Tohru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832225/
https://www.ncbi.nlm.nih.gov/pubmed/35155985
http://dx.doi.org/10.1093/rap/rkac003
_version_ 1784648677017518080
author Matsuda, Shogo
Yamamoto, Mahiro
Kotani, Takuya
Takeuchi, Tohru
author_facet Matsuda, Shogo
Yamamoto, Mahiro
Kotani, Takuya
Takeuchi, Tohru
author_sort Matsuda, Shogo
collection PubMed
description
format Online
Article
Text
id pubmed-8832225
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-88322252022-02-11 Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report Matsuda, Shogo Yamamoto, Mahiro Kotani, Takuya Takeuchi, Tohru Rheumatol Adv Pract Letter to the Editor (Case report) Oxford University Press 2022-02-10 /pmc/articles/PMC8832225/ /pubmed/35155985 http://dx.doi.org/10.1093/rap/rkac003 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor (Case report)
Matsuda, Shogo
Yamamoto, Mahiro
Kotani, Takuya
Takeuchi, Tohru
Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report
title Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report
title_full Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report
title_fullStr Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report
title_full_unstemmed Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report
title_short Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report
title_sort combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report
topic Letter to the Editor (Case report)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832225/
https://www.ncbi.nlm.nih.gov/pubmed/35155985
http://dx.doi.org/10.1093/rap/rkac003
work_keys_str_mv AT matsudashogo combinationofimmunosuppressivetherapyandnintedanibimprovescapillaroscopicchangesinsystemicsclerosisinterstitiallungdiseaseacasereport
AT yamamotomahiro combinationofimmunosuppressivetherapyandnintedanibimprovescapillaroscopicchangesinsystemicsclerosisinterstitiallungdiseaseacasereport
AT kotanitakuya combinationofimmunosuppressivetherapyandnintedanibimprovescapillaroscopicchangesinsystemicsclerosisinterstitiallungdiseaseacasereport
AT takeuchitohru combinationofimmunosuppressivetherapyandnintedanibimprovescapillaroscopicchangesinsystemicsclerosisinterstitiallungdiseaseacasereport